CMP: 32

Indraprastha Medical Corporation Limited is a super specialty hospital commissioned in December 1995 in collaboration with the New Delhi administration. The hospital houses over 50 medical specialties including multi-organ transplants, non-invasive neuro-surgeries and day care procedures.

Indraprastha Medical Corporation is a safe buy in small cap space. Its currently trading at a P/E of less than 10 with amazingly high dividend yields of close to 5% in the last 12 months. Minimal liabilities. Revenues have grown steadily from 232 Crores to 458 Crores in the last 5 years. Profits have also risen in similar lines from less than 15 Crores to over 30 Crores in the same period. NPM has marginally improved from little over 6% to close to 7% over 5 years. Considering recession lows of 20, current levels are safe to buy for long term gains.